Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer
|ClinicalTrials.gov Identifier: NCT01275872|
Recruitment Status : Completed
First Posted : January 13, 2011
Last Update Posted : November 1, 2011
The purpose of this study is to determine whether Guided Imagery and Progressive Muscle Relaxation techniques are effective in the management of pain, fatigue, nausea-vomit, anxiety and depression in patients with either prostate or breast cancer.
This study includes a total of 200 patients with prostate and breast cancer randomly assigned to either a control or intervention group.
The intervention group received in total 4 sessions of Guided Imagery (protocol floating on a cloud) and Progressive Muscle Relaxation (breathing exercises and use of 11 groups of muscle progressively tensing and relaxing).
Measurements included the assessment of pain, fatigue, nausea-vomit, depression, anxiety and quality of life. Additionally, saliva samples were collected prior and after the sessions as to assess saliva cortisol and saliva α-amylase.
The same measurements were received by the patients of the control group as to allow comparisons.
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer Prostate Cancer||Other: Guided Imagery and Progressive Muscle Relaxation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||200 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||A Randomized Clinical Trial on the Effect of Guided Imagery and Progressive Muscle Relaxation for the Management of Pain, Stress, Anxiety and Depression as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer|
|Study Start Date :||April 2010|
|Actual Primary Completion Date :||July 2011|
|Actual Study Completion Date :||October 2011|
|Experimental: Guided Imagery and Progressive Muscle Relaxation||
Other: Guided Imagery and Progressive Muscle Relaxation
4 supervised sessions per patient for 4 weeks additional to daily unsupervised sessions
- Stress [ Time Frame: 20 months ]Saliva α-amylase and saliva cortisol
- Quality of Life [ Time Frame: 20 months ]
- Fatigue [ Time Frame: 20 months ]
- Anxiety [ Time Frame: 20 months ]
- Depression [ Time Frame: 20 months ]
- Nausea-vomit [ Time Frame: 20 months ]
- Pain [ Time Frame: 20 months ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01275872
|Bank of Cyprus Oncology Centre|
|Nicosia, Cyprus, 2006|
|Principal Investigator:||Andreas I Charalambous, PhD||Cyprus University of Technology|